Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension

Clinical Science

Volumn 114, Issue 1-2, 2008, Pages 131-137

  Xue, Hao ^a   Wang, Shuxia ^a   Wang, Hu ^a   Sun, Kai ^a   Song, Xiaodong ^a   Zhang, Weili ^a   Fu, Chunyan ^a   Han, Yunfeng ^a   Hui, Rutai ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Atrial natriuretic peptide (ANP); Cardiovascular disease; Gene polymorphism; Hypertension; Left ventricular hypertrophy (LVH)

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; ECHOGRAPHY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PHENOTYPE;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 38349078259     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070109     Document Type: Article

References (27)

1. Schillaci, G., Verdecchia, P., Porcellati, G., Cuccurullo, O., Cosco, C. and Perticone, F. (2000) Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35, 580-586
2. Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. and Castelli, W. P. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566
3. Bikkina, M., Levy, D., Evans, J. C. et al. (1994) Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA, J. Am. Med. Assoc. 272, 33-36
4. Deschepper, C. F., Boutin-Ganache, I., Zahabi, A. and Jiang, Z. (2002) In search of cardiovascular candidate genes: interactions between phenotypes and genotypes. Hypertension 39, 332-336
5. Levin, E. R., Gardner, D. G. and Samson, W. K. (1998) Natriuretic peptides. N. Engl. J. Med. 339, 321-328
6. McKinsey, T. A. and Olson, E. N. (1999) Cardiac hypertrophy: sorting out the circuitry. Curr. Opin. Genet. Dev. 9, 267-274
7. Nishikimi, T., Yoshihara, F., Morimoto, A. et al. (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28, 22-30
8. Yasumoto, K., Takata, M., Ueno, H., Tomita, S., Tomoda, F. and Inoue, H. (1999) Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am. J. Hypertens. 12, 921-924
9. Klinger, J. R., Petit, R. D., Curtin, L. A. et al. (1993) Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress. ANP. J. Appl. Physiol. 75, 198-205
10. Rubattu, S., Bigatti, G., Evangelista, A. et al. (2006) Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 48, 499-505
11. World Health Organization, International Society of Hypertension Writing Group. (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21, 1983-1992
12. Cockcroft, D. W. and Gauh, M. H. (1976) Prediction of creatinine clearance from serum creatinine. Nephron. 16, 31-41
13. Tajik, A. J., Seward, J. B., Hagler, D. J., Mair, D. D. and Lie, J. T. (1978) Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin. Proc. 53, 271-303
14. Sahn, D. J., DeMaria, A., Kisslo, J. and Weyman, A. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58, 1072-1083
15. Devereux, R. B., Alonso, D. R., Lutas, E. M. et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57, 450-458
16. de Simone, G., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A. and Laragh, J. H. (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J. Am. Coll. Cardiol. 25, 1056-1062
17. Ganau, A., Devereux, R. B., Roman, M. J. et al. (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 19, 1550-1558
18. Leadon, S. A. and Cerutti, P. A. (1982) A rapid and mild procedure of the isolation of DNA from mammalian cells. Anal. Biochem. 120, 282-288
19. Carrier, L., Bonne, G., Bahrend, E. et al. (1997) Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ. Res. 80, 427-434
20. Pan, M., Zh, J. H., Liu, Z. H. et al. (2007) Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension. Hypertens. Res. 30, 31-37
21. Stella, P., Bigatti, G., Tizzoni, L. et al. (2004) Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 43, 265-270
22. Fu, Y., Katsuya, T., Matsuo, A. et al. (2004) Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy. Hypertens. Res. 27, 933-938
23. Kato, N., Sugiyama, T., Morita, H. et al. (2000) Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin. Sci. 98, 251-258
24. Rahmutula, D., Nakayama, T., Soma, M. et al. (2001) Association study between the variants of the human ANP gene and essential hypertension. Hypertens. Res. 24, 291-294
25. Patel, J. B., Valencik, M. L., Pritchett, A. M., Burnett, J. C., McDonald, J. A. and Redfield, M. M. (2005) Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload. Am. J. Physiol. Heart Circ. Physiol. 289, H777-H784
26. Sullivan, J. M., Vander Zwaag, R. V., el-Zeky, F., Ramanathan, K. B. and Mirvis, D. M. (1993) Left ventricular hypertrophy: effect on survival. J. Am. Coll. Cardiol. 22, 508-513
27. Schunkert, H., Hense, H. W., Holmer, S. R. et al. (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330, 1634-1638